IDiyas

For the Inventor, By the Inventor

Trondheim, Norway

Avexxin As


USPTO Granted Patents = 22



Forward Citations = 54

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Berit Johansen (19 out of 19 patents)

silverMedal Inger-Reidun Aukrust (7 out of 7 patents)

bronzeMedal George Kokotos (7 out of 11 patents)

4.  Marcel Sanderberg (4 out of 4 patents)

5.  Marit Anthonsen (4 out of 4 patents)

6.  Wenche Sjursen (4 out of 4 patents)

7.  Lars Skattebol (4 out of 7 patents)

8.  Anne Kristen Holmeide (4 out of 4 patents)

9.  Marcel Sandberg (3 out of 7 patents)

10.  Efrosini Barbayianni (3 out of 4 patents)

11.  Thomas Brimert (2 out of 9 patents)

12.  Astrid Jullumstrø Feuerherm (2 out of 2 patents)

13.  Johan Evenäs (2 out of 4 patents)

14.  Kildahl-Andersen Geir (2 out of 2 patents)

15.  Victoria Magrioti (2 out of 3 patents)


22 patents:

1. 11691959 - Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds (2023-07-04),
2. 11439625 - Combination therapy for proliferative diseases (2022-09-13),
3. 11351127 - Pharmaceutical composition (2022-06-07),
4. 11034666 - Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds (2021-06-15),
5. 10953004 - Combination therapy for proliferative diseases (2021-03-23),
6. 10851114 - 2-oxothiatole compounds having activity as cPLAinhibitors for the treatment of inflammatory disorders and hyperproliferative disorders (2020-12-01),
7. 10758499 - Dermatitis treatment (2020-09-01),
8. 10370344 - 2-oxothiazole compounds and method of using same for chronic inflammatory disorders (2019-08-06),
9. 10259801 - Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compounds (2019-04-16),
10. 10183911 - Process for the preparation of a polyunsaturated ketone compound (2019-01-22),
11. 10150781 - 2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders (2018-12-11),
12. 10093618 - Process for the preparation of a polyunsaturated ketone compound (2018-10-09),
13. 10085953 - Skin cancer treatment (2018-10-02),
14. 10085952 - Dermatitis treatment (2018-10-02),
15. 9682930 - Rheumatoid arthritis treatment (2017-06-20),
Avexxin AS is a pharmaceutical company specializing in the research, development, and commercialization of innovative therapeutics for the treatment of inflammatory diseases. With a focus on leveraging cutting-edge technologies, Avexxin aims to provide effective solutions to patients and healthcare providers worldwide. Through collaboration with renowned experts and strategic partnerships, Avexxin strives to improve patients' lives and address unmet medical needs in the field of inflammation.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
22 Patents

#7 in Trondheim

#69 in Norway

#27,846 in the World

...
Trondheim, Norway

Avexxin As

Forward Citations = 54

35 inventors:

goldMedal Berit Johansen (19 out of 19 patents)

silverMedal Inger-Reidun Aukrust (7 out of 7 patents)

bronzeMedal George Kokotos (7 out of 11 patents)

4.  Marcel Sanderberg (4 out of 4 patents)

5.  Marit Anthonsen (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…